HB 302: DOH; AG; Medical Cannabis; Medical Cannabis Dispensaries; Patient Records; Access; Provider-Patient Relationships; Inter-Dispensary Sales; Criminal Penalties; Nuisance Abatement and Mitigation; Medical Cannabis Registry and Regulation Special Fund; Cannabis Cultivator License; Appropriation

A BILL FOR AN ACT

RELATING TO CANNABIS.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

PART I

     SECTION 1.  The legislature finds that access for qualifying patients and primary caregivers to medical cannabis and particularly licensed medical cannabis dispensaries remains challenging due to limited access to medical providers, delays in obtaining allowed access to enter and purchase medical cannabis, and the availability of cannabis through a thriving illicit market.

     The legislature further finds that registration for the medical cannabis program has decreased in the last few years.  While the number of registered medical cannabis patients reached its peak in August 2021, with 35,444 card-holding patients, since then, the number of patients has decreased over fifteen per cent to 30,035 by November 2024.  This appears to indicate that residents are shifting away from licensed medical cannabis dispensaries, and instead are obtaining their medical cannabis from elsewhere due to administrative barriers, delays in registering, and the ease and lower costs in obtaining cannabis elsewhere.

     The legislature also finds that this apparent shift away from licensed medical cannabis dispensaries toward the illicit market undermines the purposes of the medical cannabis program in ensuring patient safety, product safety, and public safety.

     The legislature additionally finds that Act 34, Session Laws of Hawaii 2021, amended existing law governing physicians by eliminating the requirement for a physician-patient relationship to be established by an initial in-person consultation, and authorized the relationship to be established via telehealth.

     The purpose of this part is to make various amendments to the medical use of cannabis and medical cannabis dispensaries laws by:

     (1)  Authorizing the department of health to inspect a qualifying patient's medical records that are held by the physician, advanced practice registered nurse, or hospice provider who issued a written certification for the qualifying patient;

     (2)  Amending definitions of "qualifying patient" and "written certification" and adding a definition of "primary treating medical provider";

     (3)  Clarifying the conditions of use for the medical use of cannabis;

     (4)  Authorizing the establishment of a provider-patient relationship via telehealth for purposes of issuing written certifications and limiting the maximum fee a provider may assess for issuing a written certification;

     (5)  Authorizing the sale of hemp products and accessories to the medical use of cannabis at retail dispensing locations, except in the waiting room; and

     (6)  Clarifying the transportation requirements for certain types of dispensary-to-dispensary purchases of cannabis or manufactured cannabis products.

     SECTION 2.  Chapter 329, Hawaii Revised Statutes, is amended by adding a new section to part IX to be appropriately designated and to read as follows:

     "§329-     Qualifying patient medical records; inspection and enforcement; authority.  (a)  The department may inspect a qualifying patient's medical records held by the physician, advanced practice registered nurse, or hospice provider who issued a written certification for the qualifying patient.

     (b)  The department may suspend or revoke the ability to issue a written certification for any physician, advanced practice registered nurse, or hospice provider who refuses inspection of a qualifying patient's medical records by the department pursuant to this section.

     (c)  The department may suspend or revoke the ability to issue a written certification for any physician, advanced practice registered nurse, or hospice provider whose medical records do not comply with the requirements of this chapter."

     SECTION 3.  Section 329-121, Hawaii Revised Statutes, is amended as follows:

     1.  By adding a new definition to be appropriate inserted and to read:

     ""Primary treating medical provider" means a physician or an advanced practice registered nurse located in, and with an active unrestricted license to practice in, the State who, within the physician's or advanced practice registered nurse's scope of practice and individual competency, is primarily responsible for the treatment and ongoing care of the qualifying patient and has determined that the potential benefits of the medical use of cannabis are likely to outweigh the associated health risks for the qualifying patient."

     2.  By amending the definition of "qualifying patient" to read:

     ""Qualifying patient" means a person who [has]:

     (1)  Has been diagnosed [by a physician or advanced practice registered nurse] as having a debilitating medical condition[.] by a physician or advanced practice registered nurse who has certified in writing that, in the physician's or advanced practice registered nurse's professional opinion, the benefit of the medical use of cannabis would likely outweigh the health risks for the person;

     (2)  Has been diagnosed as having a condition other than a debilitating medical condition by the person's primary treating medical provider who has certified in writing that, in the primary treating medical provider's professional opinion, the potential benefits of the medical use of cannabis would likely outweigh the health risks for the person; or

     (3)  Is receiving hospice care and the hospice provider licensed in the State has certified in writing that the person is receiving hospice care."

     3.  By amending the definition of "written certification" to read:

     ""Written certification" means the qualifying patient's medical records or a statement signed by a qualifying patient's physician [or], advanced practice registered nurse, or hospice provider, stating that in the physician's [or], advanced practice registered nurse's, or hospice provider's professional opinion, the qualifying patient has a [debilitating medical condition  and] condition for which the potential benefits of the medical use of cannabis would likely outweigh the health risks for the qualifying patient.  The department of health may require, through its rulemaking authority, that all written certifications comply with a designated form.  "Written certifications" are valid for one year from the time of signing; provided that the department of health may allow for the validity of any written certification for three years if the qualifying patient's physician or advanced practice registered nurse states that the patient's [debilitating medical] condition is chronic in nature."

     SECTION 4.  Section 329-122, Hawaii Revised Statutes, is amended by amending subsections (a) and (b) to read as follows:

     "(a)  Notwithstanding any law to the contrary, the medical use of cannabis by a qualifying patient eighteen years of age or older shall be permitted only if:

    [(1)  The qualifying patient has been diagnosed by a physician or advanced practice registered nurse as having a debilitating medical condition;

     (2)  The qualifying patient's physician or advanced practice registered nurse has certified in writing that, in the physician's or advanced practice registered nurse's professional opinion, the potential benefits of the medical use of cannabis would likely outweigh the health risks for the particular qualifying patient; and

     (3)] (1)  The physician, advanced practice registered nurse, or hospice provider who has determined the patient to be a qualifying patient has explained the potential risks and benefits of the medical use of cannabis to the qualifying patient and documented in the qualifying patient's medical record that the qualifying patient understands the potential risks and benefits of the medical use of cannabis; and

     (2)  The amount of cannabis possessed by the qualifying patient does not exceed an adequate supply.

     (b)  [Subsection (a) shall not apply to] Notwithstanding any law to the contrary, the medical use of cannabis by a qualifying patient under the age of eighteen years[, unless:] shall be permitted only if:

     (1)  The [qualifying patient's] physician [or], advanced practice registered nurse, or hospice provider who has determined the patient to be a qualifying patient has explained the potential risks and benefits of the medical use of cannabis to the qualifying patient and to a parent, guardian, or person having legal custody of the qualifying patient[;] and documented in the qualifying patient's medical record that the qualifying patient and the parent, guardian, or person having legal custody of the qualifying patient understand the potential risks and benefits of the medical use of cannabis; and

     (2)  A parent, guardian, or person having legal custody consents in writing to:

          (A)  Allow the qualifying patient's medical use of cannabis;

          (B)  Serve as the qualifying patient's primary caregiver; and

          (C)  Control the acquisition of the cannabis, the dosage, and the frequency of the medical use of cannabis by the qualifying patient."

     SECTION 5.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  A written certification issued pursuant to this subsection shall originate from within the State.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient[.]; provided that nothing under this part shall require that the bona fide physician-patient relationship or bona fide advanced practice registered nurse‑patient relationship be established by conducting an initial in-person consultation.  Any fees assessed by a certifying physician or advanced practice registered nurse to issue a written certification pursuant to this subsection shall not exceed an amount equal to three times the amount of the fee charged by the department of health to issue a registration certificate pursuant to subsection (b).  All current active medical cannabis permits shall be honored through their expiration date."

     SECTION 6.  Section 329-126, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:

     "(b)  For purposes of this section, a bona fide physician‑patient relationship may be established via telehealth, as defined in section 453-1.3(j), and a bona fide advanced practice registered nurse-patient relationship may be established via telehealth, as defined in section 457-2; provided that nothing under this part shall require that treatment recommendations that include certifying a patient for the medical use of cannabis via telehealth [shall] be allowed only after an initial in-person consultation between the certifying physician or advanced practice registered nurse and the patient."

     SECTION 7.  Section 329D-1, Hawaii Revised Statutes, is amended as follows:

1.  By amending the definition of "retail dispensing location" to read:

     ""Retail dispensing location" means an establishment owned, operated, or subcontracted by a medical cannabis dispensary where cannabis [and], manufactured cannabis products, hemp products, and accessories to the medical use of cannabis, including but not limited to rolling papers, rolling trays, grinders, and vaporizers, are made available for retail sale to a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient."

     2.  By amending the definition of "waiting room" to read:      ""Waiting room" means a designated area at the public entrance of a retail dispensing location that may be accessed by a member of the general public who is waiting for, assisting, or accompanying a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient who enters or remains on the premises of a retail dispensing location for the purpose of a transaction conducted pursuant to sections 329D-6 and 329D-13; provided that the storage, display, and retail sale of cannabis [and], manufactured cannabis products, hemp products, and accessories to the medical use of cannabis, including but not limited to rolling papers, rolling trays, grinders, and vaporizers, shall be prohibited within the waiting room area."

     SECTION 8.  Section 329D-6, Hawaii Revised Statutes, is amended by amending subsection (r) to read as follows:

     "(r)  A dispensary may purchase cannabis and manufactured cannabis products from another dispensary.  The department shall authorize a dispensary to purchase cannabis and manufactured cannabis products from another dispensary in a manner prescribed by the department by rules adopted pursuant to section 329D-27; provided that:

     (1)  The selling dispensary may transport not more than eight hundred ounces, or other amounts with prior approval by the department, of cannabis or manufactured cannabis products to the purchasing dispensary within a thirty-day period; provided further that cannabis and manufactured cannabis products purchased pursuant to this section intended for:

          (A)  Direct retail sale to qualifying patients shall meet all applicable packaging, labeling, and testing requirements at the time of transport to the purchasing dispensary's production center or one of its retail dispensing locations; and

          (B)  Further manufacturing by the purchasing dispensary at the time of transportation shall be transported to the purchasing dispensary's production center;

     (2)  The cannabis and manufactured cannabis products are transported between the dispensaries for medical sales, scientific use, or other legitimate purposes approved by the State; [and]

     (3)  The selling dispensary shall submit a transport manifest of the cannabis or manufactured cannabis products to be sold to the department before the sale is made, after which the selling dispensary may immediately proceed with the transfer of the cannabis or manufactured cannabis products; and

    [(3)] (4)  Nothing in this subsection shall relieve any dispensary of its responsibilities and obligations under this chapter and chapter 329."

     SECTION 9.  Section 453-1.3, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:

     "(c)  Treatment recommendations made via telehealth, including issuing a prescription via electronic means, shall be held to the same standards of appropriate practice as those in traditional physician-patient settings that do not include [[]an[]] in-person visit but in which prescribing is appropriate, including on-call telephone encounters and encounters for which a follow-up visit is arranged.  Issuing a prescription based solely on an online questionnaire is not treatment for the purposes of this section and does not constitute an acceptable standard of care.  For the purposes of prescribing opiates [or certifying a patient for the medical use of cannabis], a physician-patient relationship shall only be established after an in-person consultation between the prescribing physician and the patient."

PART II

     SECTION 10.  The purpose of this part is to establish criminal penalties for the unlicensed operation of a medical cannabis dispensary.

     SECTION 11.  Chapter 329D, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:

     "§329D-     Unlicensed operation of a dispensary; criminal penalty.  (a)  No person shall intentionally, knowingly, or recklessly operate a dispensary without a license issued by the department pursuant to this chapter.

     (b)  No person shall intentionally, knowingly, or recklessly operate any search platform, web hosting service, social media platform, or other service that posts information advertising the sale of cannabis or manufactured cannabis products by a person or entity engaged in the production, manufacture, or sale of cannabis and manufactured cannabis products without a license issued by the department pursuant to this chapter.

     (c)  The department shall issue a cease and desist notice to any person who violates subsections (a) or (b); provided that the department shall issue the cease and desist notice before initiating any criminal proceedings.

     (d)  Any person who violates subsection (a) shall be guilty of a class C felony.  Any person who violates subsection (b) shall be guilty of a misdemeanor.

     (e)  It shall be an affirmative defense to subsection (b) that the person operating any search platform, web hosting service, social media platform, or other service that posts information advertising the sale of cannabis or manufactured cannabis products had requested, examined, and reasonably relied upon a license that appeared to have been issued by the department that was shown to the person by the unlicensed person or unlicensed entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products establishing that the unlicensed person or unlicensed entity was licensed by the department to engage in the production, manufacture, or sale of cannabis or manufactured cannabis products pursuant to this chapter.  The failure of the person operating any search platform, web hosting service, social media platform, or other service that posts information advertising the sale of cannabis and manufactured cannabis products to request and examine a license issued by the department from the unlicensed person or unlicensed entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products before providing access to any search platform, web hosting service, social media platform, or other service that posts information advertising the sale of cannabis and manufactured cannabis products shall be construed against the person operating the search platform, web hosting service, social media platform, or other service that posts information advertising the sale of cannabis and manufactured cannabis products and form a conclusive basis for the person's violation of this section.

     (f)  This section shall not apply to:

     (1)  Hemp processors or hemp product retailers with a valid permit under chapter 328G; or

     (2)  Primary caregivers registered under chapter 329 who are acting within the scope of their registration."

PART III

     SECTION 12.  The purpose of this part is to:

     (1)  Authorize expenditures from the medical cannabis registry and regulation special fund to fund programs for the mitigation and abatement of nuisances related to illegal cannabis and hemp products or medical cannabis dispensaries; and

     (2)  Appropriate funds to the department of the attorney general's drug nuisance abatement unit for these purposes.

     SECTION 13.  Section 28-131, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:

     "(c)  The purpose of the drug nuisance abatement unit shall be to provide for the effective enforcement and prosecution of those violations of the drug nuisance abatement laws under chapter 712, part V but only for offenses related to drugs and intoxicating compounds as provided under chapter 712, part IV[.] and violations of chapter 329D as provided under section 712‑1270.  The drug nuisance [[]abatement[]] unit may also review and take appropriate action on drug nuisance complaints of any citizen of the State, or drug nuisances that are discovered by the unit in carrying out its activities."

     SECTION 14.  Section 321-30.1, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  There is established within the state treasury the medical cannabis registry and regulation special fund.  The fund shall be expended at the discretion of the director of health:

     (1)  To establish and regulate a system of medical cannabis dispensaries in the State;

     (2)  To offset the cost of the processing and issuance of patient registry identification certificates and primary caregiver registration certificates;

     (3)  To fund positions and operating costs authorized by the legislature;

     (4)  To establish and manage a secure and confidential database;

     (5)  To fund public education as required by section 329D‑26;

     (6)  To fund substance abuse prevention and education programs; [and]

     (7)  To fund programs for the mitigation and abatement of nuisances relating to illegal cannabis and hemp products and chapter 329D; and

    [(7)] (8)  For any other expenditure necessary, consistent with this chapter and chapter 329D, to implement medical cannabis registry and regulation programs."

     SECTION 15.  There is appropriated out of the medical cannabis registry and regulation special fund the sum of $750,000 or so much thereof as may be necessary for fiscal year 2025-2026 and the same sum or so much thereof as may be necessary for fiscal year 2026-2027 for the department of the attorney general to enforce, and mitigate nuisances relating to, illegal cannabis and hemp products and chapter 329D, Hawaii Revised Statutes, and to establish, recruit, and hire the following positions:

     (1)  Four full-time equivalent (4.0 FTE) investigator V positions;

     (2)  One full-time equivalent (1.0 FTE) investigator IV position; and

     (3)  One full-time equivalent (1.0 FTE) analyst position.

     The sums appropriated shall be expended by the attorney general for the purposes of this part.

PART IV

     SECTION 16.  The purpose of this part is to prohibit the cultivation of cannabis without a cannabis cultivator license issued by the department of health.

     SECTION 17.  Chapter 329D, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:

     "§329D-     Cannabis cultivator; license required.  (a)  Notwithstanding section 329D-24, it shall be unlawful for any person to cultivate cannabis without a license issued by the department pursuant to this section.

     (b)  A cannabis cultivator license shall authorize the licensee to:

     (1)  Acquire and cultivate cannabis plants, seeds, cuttings, or clones; and

     (2)  Distribute cannabis plants and cannabis flower to a medical cannabis dispensary.

     (c)  The department shall issue no more than one cannabis cultivator license for each person.

     (d)  A person issued a cannabis cultivator license under this section shall meet all production facility and processing requirements of this chapter."

PART V

     SECTION 18.  This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.

     SECTION 19.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 20.  This Act shall take effect on July 1, 2025; provided that part IV of this Act shall take effect on January 1, 2028; provided further that the amendments made to section 453‑1.3(c), Hawaii Revised Statutes, by section 9 of this Act shall not be repealed when that section is reenacted on December 31, 2025, pursuant to section 8 of Act 107, Session Laws of Hawaii 2023.

Report Title:

DOH; AG; Medical Cannabis; Medical Cannabis Dispensaries; Patient Records; Access; Provider-Patient Relationships; Inter-Dispensary Sales; Criminal Penalties; Nuisance Abatement and Mitigation; Medical Cannabis Registry and Regulation Special Fund; Cannabis Cultivator License; Appropriation

Description:

Part I:  Authorizes DOH to inspect qualifying patient medical records held by the physician, advanced practice registered nurse, or hospice provider who issued a written certification for the qualifying patient.  Amends and adds definitions for purposes of the medical use of cannabis law.  Clarifies the conditions of use for the medical use of cannabis.  For purposes of issuing written certifications, authorizes the establishment of a provider-patient relationship via telehealth and limits the maximum amount of fees that can be assessed by providers.  Authorizes the sale of hemp products and accessories for the medical use of cannabis at retail dispensing locations, except in waiting rooms.  Clarifies transportation requirements for certain inter-dispensary sales of cannabis and manufactured cannabis products.  Part II:  Establishes criminal penalties for the unlicensed operation of a medical cannabis dispensary.  Part III:  Authorizes expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances related to illegal cannabis and hemp products and medical cannabis dispensaries and appropriates funds from the Special Fund to the AG's Drug Nuisance Abatement Unit for these purposes, including establishing positions.  Part IV:  Beginning 1/1/2028, prohibits the cultivation of cannabis without a cannabis cultivator license issued by DOH.  (CD1)

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

A BILL FOR AN ACT

RELATING TO CANNABIS.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

PART I

     SECTION 1.  The legislature finds that access for qualifying patients and primary caregivers to medical cannabis and particularly licensed medical cannabis dispensaries remains challenging due to limited access to medical providers, delays in obtaining allowed access to enter and purchase medical cannabis, and the availability of cannabis through a thriving illicit market.

     The legislature further finds that registration for the medical cannabis program has decreased in the last few years.  While the number of registered medical cannabis patients reached its peak in August 2021, with 35,444 card-holding patients, since then, the number of patients has decreased over fifteen per cent to 30,035 by November 2024.  This appears to indicate that residents are shifting away from licensed medical cannabis dispensaries, and instead are obtaining their medical cannabis from elsewhere due to administrative barriers, delays in registering, and the ease and lower costs in obtaining cannabis elsewhere.

     The legislature also finds that this apparent shift away from licensed medical cannabis dispensaries toward the illicit market undermines the purposes of the medical cannabis program in ensuring patient safety, product safety, and public safety.

     The legislature additionally finds that Act 34, Session Laws of Hawaii 2021, amended existing law governing physicians by eliminating the requirement for a physician-patient relationship to be established by an initial in-person consultation, and authorized the relationship to be established via telehealth.

     Accordingly, the purpose of this part is to expand access to care by easing some of the requirements under the Uniform Controlled Substances Act and law governing the State's medical cannabis dispensary system.

     SECTION 2.  Section 329-121, Hawaii Revised Statutes, is amended by amending the definition of "debilitating medical condition" to read as follows:

     ""Debilitating medical condition" means[:

     (1)  Cancer, glaucoma, lupus, epilepsy, multiple sclerosis, rheumatoid arthritis, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, or the treatment of these conditions;

     (2)  A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following:

          (A)  Cachexia or wasting syndrome;

          (B)  Severe pain;

          (C)  Severe nausea;

          (D)  Seizures, including those characteristic of epilepsy;

          (E)  Severe and persistent muscle spasms, including those characteristic of multiple sclerosis or Crohn's disease; or

          (F)  Post-traumatic stress disorder; or

     (3)  Any other medical condition approved by the department of health pursuant to administrative rules in response to a request from a physician or advanced practice registered nurse or potentially qualifying patient.]

any condition determined by the certifying physician or advanced practice registered nurse to be appropriate for the medical use of cannabis."

     SECTION 3.  Section 329D-1, Hawaii Revised Statutes, is amended by amending the definition of "waiting room" to read as follows:

     ""Waiting room" means a designated area at the public entrance of a retail dispensing location that may be accessed by a member of the general public who is waiting for, assisting, or accompanying a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient who enters or remains on the premises of a retail dispensing location for the purpose of a transaction conducted pursuant to sections 329D-6 and 329D-13; provided that the storage, display, and retail sale of cannabis and manufactured cannabis products shall be prohibited within the waiting room area.  "Waiting room" includes an area where hemp can be sold, including but not limited to hemp products and accessories to the use of medical cannabis, such as rolling papers, rolling trays, grinders, and vaporizers."

     SECTION 4.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient[.]; provided that nothing under this part shall require that the bona fide physician-patient relationship or bona fide advanced practice registered nurse‑patient relationship be established by conducting an initial in-person consultation; provided further that the written certification under this subsection shall originate from within the State.  All current active medical cannabis permits shall be honored through their expiration date."

     SECTION 5.  Section 329-126, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:

     "(b)  For purposes of this section, a bona fide physician‑patient relationship may be established via telehealth, as defined in section 453-1.3(j), and a bona fide advanced practice registered nurse-patient relationship may be established via telehealth, as defined in section 457-2; provided that nothing under this part shall require that treatment recommendations that include certifying a patient for the medical use of cannabis via telehealth [shall] be allowed only after an initial in-person consultation between the certifying physician or advanced practice registered nurse and the patient."

     SECTION 6.  Section 329D-6, Hawaii Revised Statutes, is amended by amending subsection (r) to read as follows:

     "(r)  A dispensary may purchase cannabis and manufactured cannabis products from another dispensary.  The department shall authorize a dispensary to purchase cannabis and manufactured cannabis products from another dispensary in a manner prescribed by the department by rules adopted pursuant to section 329D-27; provided that:

     (1)  The selling dispensary may transport not more than eight hundred ounces, or other amounts with prior approval by the department, of cannabis or manufactured cannabis products to the purchasing dispensary within a thirty-day period; provided further that cannabis and manufactured cannabis products purchased pursuant to this section intended for:

          (A)  Direct retail sale to the patient shall meet all applicable packaging, labeling, and testing requirements at the time of transport to the purchasing licensee's production center or one of its retail locations; and

          (B)  Further manufacturing by the purchasing dispensary at the time of transportation shall be transported to the purchasing licensee's production center;

     (2)  The cannabis and manufactured cannabis products are transported between the dispensaries for medical sales, scientific use, or other legitimate purposes approved by the State; [and]

     (3)  The selling dispensary shall submit a transport manifest of the cannabis or manufactured cannabis products to be sold to the department before the sale is made, after which the selling dispensary may immediately proceed with the transfer of the cannabis or manufactured cannabis products; and

    [(3)] (4)  Nothing in this subsection shall relieve any dispensary of its responsibilities and obligations under this chapter and chapter 329."

     SECTION 7.  Section 453-1.3, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:

     "(c)  Treatment recommendations made via telehealth, including issuing a prescription via electronic means, shall be held to the same standards of appropriate practice as those in traditional physician-patient settings that do not include [[]an[]] in-person visit but in which prescribing is appropriate, including on-call telephone encounters and encounters for which a follow-up visit is arranged.  Issuing a prescription based solely on an online questionnaire is not treatment for the purposes of this section and does not constitute an acceptable standard of care.  For the purposes of prescribing opiates [or certifying a patient for the medical use of cannabis], a physician-patient relationship shall only be established after an in-person consultation between the prescribing physician and the patient."

PART II

     SECTION 8.  Chapter 329D, Hawaii Revised Statutes, is amended by adding two new sections to be appropriately designated and to read as follows:

     "§329D-    Unauthorized operation of a dispensary; criminal penalty.  (a)  No person shall intentionally, knowingly, or recklessly operate a dispensary without a license from the department pursuant to this chapter.

     (b)  No person shall intentionally, knowingly, or recklessly operate any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products by an unlicensed person or entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products without a license pursuant to this chapter.

     (c)  The department shall issue a cease and desist notice to any person or entity who violates subsection (a) or (b); provided that the cease and desist notice shall be issued before initiating criminal proceedings.

     (d)  Any person who violates subsection (a) shall be guilty of a class C felony.  Any person who violates subsection (b) shall be guilty of a misdemeanor.

     (e)  It shall be an affirmative defense to subsection (b) that the person operating any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products had requested, examined, and reasonably relied upon a license that appeared to have been issued by the department that was shown by the unlicensed person or unlicensed entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products establishing that the unlicensed person or unlicensed entity was licensed by the department to engage in the production, manufacture, or sale of cannabis or manufactured cannabis products pursuant to this chapter.  The failure of the person operating any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products to request and examine a license issued by the department from the unlicensed person or unlicensed entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products before providing access to any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products shall be construed against the person operating any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products and form a conclusive basis for the person’s violation of this section.

     (f)  This section shall not apply to:

     (1)  Hemp processors, hemp product retailers, or hemp produce retailers with a valid permit under chapter 328G; or

     (2)  Primary qualified caregivers registered under chapter 329 who are acting within the scope of their permit or registration.

     §329D-    Cannabis cultivator; license required.  (a)  Notwithstanding section 329D-24, it shall be unlawful for any person to cultivate cannabis without a license from the department pursuant to this section.

     (b)  A cannabis cultivator license shall authorize:

     (1)  The acquisition and cultivation of cannabis plants, seeds, cuttings, or clones; and

     (2)  The distribution of cannabis plants and cannabis flower to a medical cannabis dispensary.

     (c)  The department shall issue not more than one cannabis cultivator license for each person.

     (d)  The maximum number of cannabis cultivator licenses that may be issued by the department to the public shall not exceed       licenses.

     (e)  The maximum size of plant canopy the department may authorize for each cannabis cultivator license shall be       square feet of plant canopy for indoor cultivations and       square feet of plant canopy for outdoor cultivations, or a maximum plant count of       mature cannabis plants for each cannabis cultivator license.

     (f)  A person issued a cannabis cultivator license under this section shall meet all production facility and processing requirements under this chapter.

     (g)  For the purposes of this section, "plant canopy" means the square footage dedicated to flowering plants that are wider or taller than twelve inches.  "Plant canopy" does not include areas such as space used for the storage of fertilizers, pesticides, or other products, quarantine, or office space."

     SECTION 9.  Section 28-131, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:

     "(c)  The purpose of the drug nuisance abatement unit shall be to provide for the effective enforcement and prosecution of those violations of the drug nuisance abatement laws under chapter 712, part V but only for offenses related to drugs and intoxicating compounds as provided under chapter 712, part IV[.] and violations of chapter 329D as provided under section 712‑1270.  The drug nuisance [[]abatement[]] unit may also review and take appropriate action on drug nuisance complaints of any citizen of the State, or drug nuisances that are discovered by the unit in carrying out its activities."

     SECTION 10.  Section 321-30.1, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  There is established within the state treasury the medical cannabis registry and regulation special fund.  The fund shall be expended at the discretion of the director of health:

     (1)  To establish and regulate a system of medical cannabis dispensaries in the State;

     (2)  To offset the cost of the processing and issuance of patient registry identification certificates and primary caregiver registration certificates;

     (3)  To fund positions and operating costs authorized by the legislature;

     (4)  To establish and manage a secure and confidential database;

     (5)  To fund public education as required by section 329D‑26;

     (6)  To fund substance abuse prevention and education programs; [and]

     (7)  To fund programs for the mitigation and abatement of nuisances relating to chapter 329D; and

    [(7)] (8)  For any other expenditure necessary, consistent with this chapter and chapter 329D, to implement medical cannabis registry and regulation programs."

     SECTION 11.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient.  All current active medical cannabis permits shall be honored through their expiration date.  Any fees assessed by a certifying physician or advanced practice registered nurse to issue a written certification for a qualifying patient shall not exceed an amount equal to three times the amount of the fee charged by the department of health to issue a registration certificate pursuant to subsection (b)."

     SECTION 12.  There is appropriated out of the medical cannabis registry and regulation special fund the sum of $           or so much thereof as may be necessary for fiscal year 2025-2026 and the same sum or so much thereof as may be necessary for fiscal year 2026-2027 for the department of the attorney general to enforce, and mitigate nuisances relating to, chapter 329D, Hawaii Revised Statutes.

     The sums appropriated shall be expended by the attorney general for the purposes of this part.

PART III

     SECTION 13.  This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.

     SECTION 14.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 15.  This Act shall take effect on December 31, 2050; provided that section 8 shall take effect on January 1, 2027; provided further that the amendments made to section 453‑1.3(c), Hawaii Revised Statutes, by section 7 of this Act shall not be repealed when that section is reenacted on December 31, 2025, pursuant to section 8 of Act 107, Session Laws of Hawaii 2023.

Report Title:

DOH; Medical Cannabis; Access; Provider-Patient Relationships; Certification; Inter-Dispensary Sales; Cannabis Cultivator; Licensure; Requirement; Cease and Desist Notice; Penalty; Violations; Affirmative Defense; Conclusive Basis; Medical Cannabis Registry and Regulation Special Fund; Exceptions; Appropriations

Description:

Amends the definition of "debilitating medical condition" under the Uniform Controlled Substances Act.  Amends the definition of "waiting room" under the Medical Cannabis Dispensary System law.  Repeals the requirement that a provider-patient relationship be established in person.  Allows dispensaries to purchase cannabis and manufactured cannabis products from another dispensary for direct retail sale to a patient and further manufacturing by the purchasing dispensaries and establishes requirements for transport.  Prohibits persons from operating a medical cannabis dispensary or cultivating cannabis without a license from the Department of Health or providing certain services to persons or entities engaging in unlicensed cannabis operations.  Requires the Department of Health to issue a cease and desist notice to violators before initiating criminal proceedings.  Establishes criminal penalties.  Establishes an affirmative defense for, and a conclusive basis for certain violations.  Establishes exceptions.  Establishes a cannabis cultivator license to authorize the cultivation and distribution of cannabis plants.  Requires the Department of Health to only issue one cannabis cultivator license for each person.  Establishes limits on:  (1) the number of cannabis cultivator licenses the Department of Health may issue; (2) the maximum size of plant canopy for indoor and outdoor cultivations for each cannabis cultivator license; and (3) the maximum plant count of mature cannabis plants for each cannabis cultivator license.  Requires persons issued a cannabis cultivator license to meet the same facility and processing requirements under chapter 329D, HRS.  Authorizes expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances relating to chapter 329D, HRS.  Appropriates funds out of the Medical Cannabis Registry and Regulation Special Fund for the Department of Attorney General to enforce, and mitigate nuisances relating to, chapter 329D, HRS.  Effective 12/31/2050.  (SD2)

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

A BILL FOR AN ACT

RELATING TO CANNABIS.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

PART I

     SECTION 1.  The legislature finds that access for qualifying patients and primary caregivers to medical cannabis and particularly licensed medical cannabis dispensaries remains challenging due to limited access to medical providers, delays in obtaining allowed access to enter and purchase medical cannabis, and the availability of cannabis through a thriving illicit market.

     The legislature further finds that registration for the medical cannabis program has decreased in the last few years.  While the number of registered medical cannabis patients reached its peak in August 2021, with 35,444 card-holding patients, since then, the number of patients has decreased over fifteen per cent to 30,035 by November 2024.  This appears to indicate that residents are shifting away from licensed medical cannabis dispensaries, and instead are obtaining their medical cannabis from elsewhere due to administrative barriers, delays in registering, and the ease and lower costs in obtaining cannabis elsewhere.

     The legislature also finds that this apparent shift away from licensed medical cannabis dispensaries toward the illicit market undermines the purposes of the medical cannabis program in ensuring patient safety, product safety, and public safety.

     The legislature additionally finds that Act 34, Session Laws of Hawaii 2021, amended existing law governing physicians by eliminating the requirement for a physician-patient relationship to be established by an initial in-person consultation, and authorized the relationship to be established via telehealth.

     Accordingly, the purpose of this part is to expand access to care by easing some of the requirements under the Uniform Controlled Substances Act and law governing the State's medical cannabis dispensary system.

     SECTION 2.  Section 329-121, Hawaii Revised Statutes, is amended by amending the definition of "debilitating medical condition" to read as follows:

     ""Debilitating medical condition" means[:

     (1)  Cancer, glaucoma, lupus, epilepsy, multiple sclerosis, rheumatoid arthritis, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, or the treatment of these conditions;

     (2)  A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following:

          (A)  Cachexia or wasting syndrome;

          (B)  Severe pain;

          (C)  Severe nausea;

          (D)  Seizures, including those characteristic of epilepsy;

          (E)  Severe and persistent muscle spasms, including those characteristic of multiple sclerosis or Crohn's disease; or

          (F)  Post-traumatic stress disorder; or

     (3)  Any other medical condition approved by the department of health pursuant to administrative rules in response to a request from a physician or advanced practice registered nurse or potentially qualifying patient.]

any condition determined by the certifying physician or advanced practice registered nurse to be appropriate for the medical use of cannabis."

     SECTION 3.  Section 329D-1, Hawaii Revised Statutes, is amended by amending the definition of "waiting room" to read as follows:

     ""Waiting room" means a designated area at the public entrance of a retail dispensing location that may be accessed by a member of the general public who is waiting for, assisting, or accompanying a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient who enters or remains on the premises of a retail dispensing location for the purpose of a transaction conducted pursuant to sections 329D-6 and 329D-13; provided that the storage, display, and retail sale of cannabis and manufactured cannabis products shall be prohibited within the waiting room area.  "Waiting room" includes an area where hemp can be sold, including but not limited to hemp products and accessories to the use of medical cannabis, such as rolling papers, rolling trays, grinders, and vaporizers."

     SECTION 4.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient[.]; provided that nothing under this part shall require that the bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship be established by conducting an initial in-person consultation; provided further that the written certification under this subsection shall originate from within the State.  All current active medical cannabis permits shall be honored through their expiration date."

     SECTION 5.  Section 329-126, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:

     "(b)  For purposes of this section, a bona fide physician-patient relationship may be established via telehealth, as defined in section 453-1.3(j), and a bona fide advanced practice registered nurse-patient relationship may be established via telehealth, as defined in section 457-2; provided that nothing under this part shall require that treatment recommendations that include certifying a patient for the medical use of cannabis via telehealth [shall] be allowed only after an initial in-person consultation between the certifying physician or advanced practice registered nurse and the patient."

     SECTION 6.  Section 329D-6, Hawaii Revised Statutes, is amended by amending subsection (r) to read as follows:

     "(r)  A dispensary may purchase cannabis and manufactured cannabis products from another dispensary.  The department shall authorize a dispensary to purchase cannabis and manufactured cannabis products from another dispensary in a manner prescribed by the department by rules adopted pursuant to section 329D-27; provided that:

     (1)  The selling dispensary may transport not more than eight hundred ounces, or other amounts with prior approval by the department, of cannabis or manufactured cannabis products to the purchasing dispensary within a thirty-day period; provided further that cannabis and manufactured cannabis products purchased pursuant to this section intended for:

          (A)  Direct retail sale to the patient shall meet all applicable packaging, labeling, and testing requirements at the time of transport to the purchasing licensee's production center or one of its retail locations; and

          (B)  Further manufacturing by the purchasing dispensary at the time of transportation shall be transported to the purchasing licensee's production center;

     (2)  The cannabis and manufactured cannabis products are transported between the dispensaries for medical sales, scientific use, or other legitimate purposes approved by the State; [and]

     (3)  The selling dispensary shall submit a transport manifest of the cannabis or manufactured cannabis products to be sold to the department before the sale is made, after which the selling dispensary may immediately proceed with the transfer of the cannabis or manufactured cannabis products; and

    [(3)] (4)  Nothing in this subsection shall relieve any dispensary of its responsibilities and obligations under this chapter and chapter 329."

     SECTION 7.  Section 453-1.3, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:

     "(c)  Treatment recommendations made via telehealth, including issuing a prescription via electronic means, shall be held to the same standards of appropriate practice as those in traditional physician-patient settings that do not include [[]an[]] in-person visit but in which prescribing is appropriate, including on-call telephone encounters and encounters for which a follow-up visit is arranged.  Issuing a prescription based solely on an online questionnaire is not treatment for the purposes of this section and does not constitute an acceptable standard of care.  For the purposes of prescribing opiates [or certifying a patient for the medical use of cannabis], a physician-patient relationship shall only be established after an in-person consultation between the prescribing physician and the patient."

PART II

     SECTION 8.  Chapter 329D, Hawaii Revised Statutes, is amended by adding two new sections to be appropriately designated and to read as follows:

     "§329D-    Unauthorized operation of a dispensary; criminal penalty.  (a)  It shall be unlawful for any person to operate a dispensary without a license from the department pursuant to this chapter.

     (b)  No person shall intentionally, knowingly, or recklessly operate any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products by an unlicensed person or entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products without a license pursuant to this chapter.

     (c)  The department shall issue a cease and desist notice to any person or entity who violates subsection (a) or (b); provided that the cease and desist notice shall be issued before initiating criminal proceedings.

     (d)  Any person who violates subsection (a) shall be guilty of a class C felony.

     (e)  It shall be an affirmative defense to subsection (b) that the person operating any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products had requested, examined, and reasonably relied upon a license that appeared to have been issued by the department that was shown by the unlicensed person or unlicensed entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products establishing that the unlicensed person or unlicensed entity was licensed by the department to engage in the production, manufacture, or sale of cannabis or manufactured cannabis products pursuant to this chapter.  The failure of the person operating any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products to request and examine a license issued by the department from the unlicensed person or unlicensed entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products before providing access to any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products shall be construed against the person operating any search platform, web hosting services, social media platform, or other entity that posts information advertising the sale of cannabis products and form a conclusive basis for the person’s violation of this section.

     (f)  This section shall not apply to:

     (1)  Hemp processors, hemp product retailers, or hemp produce retailers with a valid permit under chapter 328G; or

     (2)  Primary qualified caregivers registered under chapter 329 who are acting within the scope of their permit or registration.

     §329D-    Cannabis cultivator; license required.  (a)  Notwithstanding section 329D-24, it shall be unlawful for any person to cultivate cannabis without a license from the department pursuant to this section.

     (b)  A cannabis cultivator license shall authorize:

     (1)  The acquisition and cultivation of cannabis plants, seeds, cuttings, or clones; and

     (2)  The distribution of cannabis plants and cannabis flower to a medical cannabis dispensary.

     (c)  The department shall issue not more than one cannabis cultivator license for each person.

     (d)  The maximum number of cannabis cultivator licenses that may be issued by the department to the public shall not exceed       licenses.

     (e)  The maximum size of plant canopy the department may authorize for each cannabis cultivator license shall be       square feet of plant canopy for indoor cultivations and       square feet of plant canopy for outdoor cultivations, or a maximum plant count of       mature cannabis plants for each cannabis cultivator license.

     (f)  For the purposes of this section, "plant canopy" means the square footage dedicated to flowering plants that are wider or taller than twelve inches.  "Plant canopy" does not include areas such as space used for the storage of fertilizers, pesticides, or other products, quarantine, or office space."

     SECTION 9.  Section 321-30.1, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  There is established within the state treasury the medical cannabis registry and regulation special fund.  The fund shall be expended at the discretion of the director of health:

     (1)  To establish and regulate a system of medical cannabis dispensaries in the State;

     (2)  To offset the cost of the processing and issuance of patient registry identification certificates and primary caregiver registration certificates;

     (3)  To fund positions and operating costs authorized by the legislature;

     (4)  To establish and manage a secure and confidential database;

     (5)  To fund public education as required by section 329D‑26;

     (6)  To fund substance abuse prevention and education programs; [and]

     (7)  To fund programs for the mitigation and abatement of nuisances relating to chapter 329D; and

    [(7)] (8)  For any other expenditure necessary, consistent with this chapter and chapter 329D, to implement medical cannabis registry and regulation programs."

     SECTION 10.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient.  All current active medical cannabis permits shall be honored through their expiration date.  Any fees assessed by a certifying physician or advanced practice registered nurse to issue a written certification for a qualifying patient shall not exceed an amount equal to three times the amount of the fee charged by the department of health to issue a registration certificate pursuant to subsection (b)."

     SECTION 11.  There is appropriated out of the medical cannabis registry and regulation special fund the sum of $           or so much thereof as may be necessary for fiscal year 2025-2026 and the same sum or so much thereof as may be necessary for fiscal year 2026-2027 for the department of the attorney general to enforce, and mitigate nuisances relating to, chapter 329D, Hawaii Revised Statutes.

     The sums appropriated shall be expended by the director of health for the purposes of this part.

PART III

     SECTION 12.  This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.

     SECTION 13.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 14.  This Act shall take effect on December 31, 2050; provided that the amendments made to section 453-1.3(c), Hawaii Revised Statutes, by section 7 of this Act shall not be repealed when that section is reenacted on December 31, 2025, pursuant to section 8 of Act 107, Session Laws of Hawaii 2023.

Report Title:

DOH; Medical Cannabis; Access; Provider-Patient Relationships; Certification; Inter-Dispensary Sales; Cannabis Cultivator; Licensure; Requirement; Cease and Desist Notice; Penalty; Violations; Affirmative Defense; Conclusive Basis; Medical Cannabis Registry and Regulation Special Fund; Exceptions; Appropriations

Description:

Amends the definition of "debilitating medical condition" under the Uniform Controlled Substances Act.  Amends the definition of "waiting room" under the Medical Cannabis Dispensary System law.  Repeals the requirement that a provider-patient relationship be established in person.  Allows dispensaries to purchase cannabis and manufactured cannabis products from another dispensary for direct retail sale to a patient and further manufacturing by the purchasing dispensaries and establishes requirements for transport.  Prohibits persons from operating a medical cannabis dispensary or cultivating cannabis without a license from the Department of Health or providing certain services to persons or entities engaging in unlicensed cannabis operations.  Requires the Department of Health to issue a cease and desist notice to violators before initiating criminal proceedings.  Establishes criminal penalties.  Establishes an affirmative defense for, and a conclusive basis for certain violations.  Establishes exceptions.  Establishes a cannabis cultivator license to authorize the cultivation and distribution of cannabis plants.  Requires the Department of Health to only issue one cannabis cultivator license for each person.  Establishes limits on:  (1) the number of cannabis cultivator licenses the Department of Health may issue; (2) the maximum size of plant canopy for indoor and outdoor cultivations for each cannabis cultivator license; and (3) the maximum plant count of mature cannabis plants for each cannabis cultivator license.  Authorizes expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances relating to chapter 329D, HRS.  Appropriates funds out of the Medical Cannabis Registry and Regulation Special Fund for the Department of Attorney General to enforce, and mitigate nuisances relating to, chapter 329D, HRS.  Effective 12/31/2050.  (SD1)

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

A BILL FOR AN ACT

RELATING TO CANNABIS.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

     SECTION 1.  The legislature finds that access for qualifying patients and primary caregivers to medical cannabis and particularly licensed medical cannabis dispensaries remains challenging due to limited access to medical providers, delays in obtaining allowed access to enter and purchase medical cannabis, and the availability of cannabis through a thriving illicit market.

     The legislature further finds that registration for the medical cannabis program has decreased in the last few years.  While the number of registered medical cannabis patients reached its peak in August 2021, with 35,444 card-holding patients, since then, the number of patients has decreased over fifteen per cent to 30,035 by November 2024.  This appears to indicate that residents are shifting away from licensed medical cannabis dispensaries, and instead are obtaining their medical cannabis from elsewhere due to administrative barriers, delays in registering, and the ease and lower costs in obtaining cannabis elsewhere.

     The legislature also finds that this apparent shift away from licensed medical cannabis dispensaries toward the illicit market undermines the purposes of the medical cannabis program in ensuring patient safety, product safety, and public safety.

     The legislature additionally finds that in Act 34, Session Laws of Hawaii 2021, eliminated the requirement for a physician-patient relationship to be established by an initial in-person consultation, and authorized the relationship to be established via telehealth.

     Accordingly, the purpose of this Act is to expand access to care by easing some of the burdens upon qualifying patients and primary caregivers.  Specifically, this Act repeals the requirement that a provider-patient relationship be established in person.

     SECTION 2.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient[.]; provided that nothing under this part shall require that the bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship be established by conducting an initial in-person consultation; provided further that the written certification under this subsection shall originate from within the State.  All current active medical cannabis permits shall be honored through their expiration date."

     SECTION 3.  Section 329-126, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:

     "(b)  For purposes of this section, a bona fide physician-patient relationship may be established via telehealth, as defined in section 453-1.3(j), and a bona fide advanced practice registered nurse-patient relationship may be established via telehealth, as defined in section 457-2; provided that nothing under this part shall require that treatment recommendations that include certifying a patient for the medical use of cannabis via telehealth [shall] be allowed only after an initial in-person consultation between the certifying physician or advanced practice registered nurse and the patient."

     SECTION 4.  Section 453-1.3, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:

     "(c)  Treatment recommendations made via telehealth, including issuing a prescription via electronic means, shall be held to the same standards of appropriate practice as those in traditional physician-patient settings that do not include [[]an[]] in-person visit but in which prescribing is appropriate, including on-call telephone encounters and encounters for which a follow-up visit is arranged.  Issuing a prescription based solely on an online questionnaire is not treatment for the purposes of this section and does not constitute an acceptable standard of care.  For the purposes of prescribing opiates [or certifying a patient for the medical use of cannabis], a physician-patient relationship shall only be established after an in-person consultation between the prescribing physician and the patient."

     SECTION 5.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 6.  This Act shall take effect on July 1, 3000; provided that the amendments made to section 453-1.3(c), Hawaii Revised Statutes, by section 4 of this Act shall not be repealed when that section is reenacted on December 31, 2025, pursuant to section 8 of Act 107, Session Laws of Hawaii 2023.

Report Title:

Medical Cannabis; Access; Provider-Patient Relationships; Certification

Description:

Repeals the requirement that a provider-patient relationship be established in person.  Effective 7/1/3000.  (HD2)

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

A BILL FOR AN ACT

RELATING TO CANNABIS.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

     SECTION 1.  The legislature finds that access for qualifying patients and primary caregivers to medical cannabis and particularly licensed medical cannabis dispensaries remains challenging due to limited access to medical providers, delays in obtaining allowed access to enter and purchase medical cannabis, and the availability of cannabis through a thriving illicit market.

     The legislature further finds that registration for the medical cannabis program has decreased in the last few years.  While the number of registered medical cannabis patients reached its peak in August 2021, with 35,444 card-holding patients, since then, the number of patients has decreased over fifteen per cent to 30,035 by November 2024.  This appears to indicate that residents are shifting away from licensed medical cannabis dispensaries, and instead are obtaining their medical cannabis from elsewhere due to administrative barriers, delays in registering, and the ease and lower costs in obtaining cannabis elsewhere.

     The legislature also finds that this apparent shift away from licensed medical cannabis dispensaries toward the illicit market undermines the purposes of the medical cannabis program in ensuring patient safety, product safety, and public safety.

     The legislature additionally finds that in Act 34, Session Laws of Hawaii 2021, eliminated the requirement for a physician-patient relationship to be established by an initial in-person consultation, and authorized the relationship to be established via telehealth.

     The legislature further finds that the department of health office of medical cannabis control and regulation has a comprehensive registration system that could temporarily allow a qualifying patient or primary caregiver to purchase medical cannabis, instead of having the patient's access to medical cannabis delayed by a few to several days while awaiting delivery of the registration card from the department.

     Accordingly, the purpose of this Act is to expand access to care by easing some of the burdens upon qualifying patients and primary caregivers.  Specifically, this Act:

     (1)  Repeals the requirement that a provider-patient relationship be established in person; and

     (2)  Allows applicants or primary caregivers to temporarily purchase medical cannabis after the submission of the applicant's certification form.

     SECTION 2.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient[.]; provided that nothing under this part shall require that the bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship be established by conducting an initial in-person consultation.  After the submission of the applicant's form but before receipt of confirmed registration from the department of health, the applicant or primary caregiver may use the submission of the applicant's form as proof and documentation authorizing the applicant or primary caregiver to enter and make a one-time purchase of cannabis from a medical cannabis dispensary licensed under chapter 329D in an amount that is no more than fifty per cent of the dispensing limits under section 329D-13.  The department of health office of medical cannabis control and regulation shall facilitate the temporary authorization for applicants and primary caregivers.  All current active medical cannabis permits shall be honored through their expiration date."

     SECTION 3.  Section 329-126, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:

     "(b)  For purposes of this section, a bona fide physician-patient relationship may be established via telehealth, as defined in section 453-1.3(j), and a bona fide advanced practice registered nurse-patient relationship may be established via telehealth, as defined in section 457-2; provided that nothing under this part shall require that treatment recommendations that include certifying a patient for the medical use of cannabis via telehealth [shall] be allowed only after an initial in-person consultation between the certifying physician or advanced practice registered nurse and the patient."

     SECTION 4.  Section 453-1.3, Hawaii Revised Statutes, is amended by amending subsection (c) to read as follows:

     "(c)  Treatment recommendations made via telehealth, including issuing a prescription via electronic means, shall be held to the same standards of appropriate practice as those in traditional physician-patient settings that do not include [[]an[]] in-person visit but in which prescribing is appropriate, including on-call telephone encounters and encounters for which a follow-up visit is arranged.  Issuing a prescription based solely on an online questionnaire is not treatment for the purposes of this section and does not constitute an acceptable standard of care.  For the purposes of prescribing opiates [or certifying a patient for the medical use of cannabis], a physician-patient relationship shall only be established after an in-person consultation between the prescribing physician and the patient."

     SECTION 5.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 6.  This Act shall take effect on July 1, 3000; provided that the amendments made to section 453-1.3(c), Hawaii Revised Statutes, by section 4 of this Act shall not be repealed when that section is reenacted on December 31, 2025, pursuant to section 8 of Act 107, Session Laws of Hawaii 2023.

Report Title:

Medical Cannabis; Access; Providers; Certification

Description:

Repeals the requirement that a provider-patient relationship be established in person.  Allows applicants or primary caregivers to temporarily purchase medical cannabis after the submission of the applicant's certification form.  Effective 7/1/3000.  (HD1)

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

A BILL FOR AN ACT

RELATING TO CANNABIS.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

     SECTION 1.  The legislature finds that access for qualifying patients and primary caregivers to medical cannabis and particularly licensed medical cannabis dispensaries remains challenging due to limited access to medical providers, delays in obtaining allowed access to enter and purchase medical cannabis, and the availability of cannabis through a thriving illicit market.

     The legislature further finds that registration for the medical cannabis program has decreased in the last few years.  While the number of registered medical cannabis patients reached its peak in August 2021, with 35,444 card-holding patients, since then, the number of patients has decreased over fifteen per cent to 30,035 by November 2024.  This appears to indicate that residents are shifting away from licensed medical cannabis dispensaries, and instead are obtaining their medical cannabis from elsewhere due to difficulties, delays in registering, and the ease and lower costs in obtaining cannabis elsewhere.

     The legislature also finds that this apparent shift away from licensed medical cannabis dispensaries toward the illicit market, undermines the purposes of the medical cannabis program in ensuring patient safety, product safety, and public safety.

     The legislature additionally finds that in 2021, Act 34, Session Laws of Hawaii 2021, eliminated the requirement for a physician-patient relationship to be established by an initial in-person consultation, and authorized the relationship to be established via telehealth.

     The legislature further finds that the department of health office of medical cannabis control and regulation has a comprehensive registration system that could temporarily allow a qualifying patient or primary caregiver to purchase medical cannabis, instead of having the patient's access to medical cannabis delayed by a few to several days while awaiting delivery of the registration card from the department.

     Accordingly, the purpose of this Act is to expand access to care by easing some of the burdens upon qualifying patients and primary caregivers.  Specifically, this Act:

     (1)  Repeals the requirement that a provider-patient relationship be established in person; and

     (2)  Allows applicants or primary caregivers to temporarily purchase medical cannabis after the submission of the applicant's certification form.

     SECTION 2.  Section 329-123, Hawaii Revised Statutes, is amended by amending subsection (a) to read as follows:

     "(a)  Physicians or advanced practice registered nurses who issue written certifications shall provide, in each written certification, the name, address, patient identification number, and other identifying information of the qualifying patient.  The department of health shall require, in rules adopted pursuant to chapter 91, that all written certifications comply with a designated form completed by or on behalf of a qualifying patient.  The form shall require information from the applicant, primary caregiver, and physician or advanced practice registered nurse as specifically required or permitted by this chapter.  The form shall require the address of the location where the cannabis is grown and shall appear on the registry card issued by the department of health.  The certifying physician or advanced practice registered nurse shall be required to have a bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship, as applicable, with the qualifying patient[.]; provided that nothing under this part shall require that the bona fide physician-patient relationship or bona fide advanced practice registered nurse-patient relationship be established by conducting an initial in-person consultation.  After the submission of the applicant's form but before receipt of confirmed registration from the department of health, the applicant or primary caregiver may use the submission of the applicant's form as proof and documentation authorizing the applicant or primary caregiver to enter and make a one-time purchase of cannabis from a medical cannabis dispensary licensed under chapter 329D in an amount that is no more than fifty per cent of the dispensing limits under section 329D-13.  The department of health office of medical cannabis control and regulation shall facilitate the temporary authorization for applicants and primary caregivers.  All current active medical cannabis permits shall be honored through their expiration date."

     SECTION 3.  Section 329-126, Hawaii Revised Statutes, is amended by amending subsection (b) to read as follows:

     "(b)  For purposes of this section, a bona fide physician-patient relationship may be established via telehealth, as defined in section 453-1.3(j), and a bona fide advanced practice registered nurse-patient relationship may be established via telehealth, as defined in section 457-2; provided that nothing under this part shall require that treatment recommendations that include certifying a patient for the medical use of cannabis via telehealth [shall] be allowed only after an initial in-person consultation between the certifying physician or advanced practice registered nurse and the patient."

     SECTION 4.  Statutory material to be repealed is bracketed and stricken.  New statutory material is underscored.

     SECTION 5.  This Act shall take effect upon its approval.

Report Title:

Medical Cannabis; Access; Providers; Certification

Description:

Repeals the requirement that a provider-patient relationship be established in person.  Allows applicants or primary caregivers to temporarily purchase medical cannabis after the submission of the applicant's certification form.

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

CONFERENCE COMMITTEE REP. NO. 255

Honolulu, Hawaii

                 , 2025

RE:    H.B. No. 302

       H.D. 2

       S.D. 2

       C.D. 1

Honorable Nadine K. Nakamura

Speaker, House of Representatives

Thirty-Third State Legislature

Regular Session of 2025

State of Hawaii

Honorable Ronald D. Kouchi

President of the Senate

Thirty-Third State Legislature

Regular Session of 2025

State of Hawaii

Madam and Sir:

     Your Committee on Conference on the disagreeing vote of the House of Representatives to the amendments proposed by the Senate in H.B. No. 302, H.D. 2, S.D. 2, entitled:

"A BILL FOR AN ACT RELATING TO CANNABIS,"

having met, and after full and free discussion, has agreed to recommend and does recommend to the respective Houses the final passage of this bill in an amended form.

     The purpose of this measure is to make various amendments to the medical use of cannabis and medical cannabis dispensaries laws by:

     (1)  Amending the definition of "debilitating medical condition";

     (2)  Authorizing the sale of hemp products and accessories to the use of medical cannabis in a medical cannabis dispensary waiting room;

     (3)  Authorizing the establishment of a provider-patient relationship via telehealth for purposes of issuing written certifications and limiting the maximum fee a provider may assess for issuing a written certification;

     (4)  Clarifying the transportation requirements for certain types of dispensary-to-dispensary purchases of cannabis or manufactured cannabis products;

     (5)  Beginning January 1, 2027:

          (A)  Establish criminal penalties for the unlicensed operation of a medical cannabis dispensary; and

          (B)  Prohibit the cultivation of cannabis without a license issued by the Department of Health; and

     (6)  Authorize expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances related to medical cannabis dispensaries and appropriate funds to the Attorney General's Drug Nuisance Abatement Unit for these purposes.

     Your Committee on Conference has amended this measure by:

     (1)  Reverting to the existing statutory definition of "debilitating medical condition";

     (2)  Authorizing the Department of Health to inspect a qualifying patient's medical records that are held by the physician, advanced practice registered nurse, or hospice provider who issued a written certification for the qualifying patient;

     (3)  Amending the definitions of "qualifying patient" and "written certification" and adding a definition for "primary treating medical provider";

     (4)  Clarifying the conditions of use for the medical use of cannabis;

     (5)  Authorizing the sale of hemp products and accessories to the medical use of cannabis at retail dispensing locations, except in the waiting room;

     (6)  Establishing criminal penalties for the unlicensed operation of a medical cannabis dispensary beginning July 1, 2025, rather than January 1, 2027;

     (7)  Authorizing expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances related to illegal cannabis and hemp products as well as medical cannabis dispensaries;

     (8)  Inserting an appropriation of $750,000 from the Medical Cannabis Registry and Regulation Special Fund for the mitigation and abatement of nuisances related to illegal cannabis and hemp products and medical cannabis dispensaries, including the establishment of positions;

     (9)  Prohibiting the cultivation of cannabis without a license issued by the Department of Health beginning January 1, 2028, rather than January 1, 2027, and deleting certain provisions relating to the maximum number of cannabis cultivator licenses and maximum plant canopy size;

     (10) Changing the effective date to July 1, 2025; and

     (11) Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.

     As affirmed by the record of votes of the managers of your Committee on Conference that is attached to this report, your Committee on Conference is in accord with the intent and purpose of H.B. No. 302, H.D. 2, S.D. 2, as amended herein, and recommends that it pass Final Reading in the form attached hereto as H.B. No. 302, H.D. 2, S.D. 2, C.D. 1.

Respectfully submitted on behalf of the managers:

STAND. COM. REP. NO. 1816

Honolulu, Hawaii

RE:    H.B. No. 302

       H.D. 2

       S.D. 2

Honorable Ronald D. Kouchi

President of the Senate

Thirty-Third State Legislature

Regular Session of 2025

State of Hawaii

Sir:

     Your Committees on Judiciary and Ways and Means, to which was referred H.B. No. 302, H.D. 2, S.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO CANNABIS,"

beg leave to report as follows:

     The purpose and intent of this measure is to:

     (1)  Amend the definition of "debilitating medical condition" under the Uniform Controlled Substances Act;

     (2)  Amend the definition of "waiting room" under the Medical Cannabis Dispensary System law;

     (3)  Repeal the requirement that a provider-patient relationship be established in person;

     (4)  Allow dispensaries to purchase cannabis and manufactured cannabis products from another dispensary for direct retail sale to a patient and further manufacturing by the purchasing dispensaries and establishes requirements for transport;

     (5)  Prohibit persons from operating a medical cannabis dispensary or cultivating cannabis without a license from the Department of Health or providing certain services to persons or entities engaging in unlicensed cannabis operations;

     (6)  Require the Department of Health to issue a cease and desist notice to violators before initiating criminal proceedings;

     (7)  Establish criminal penalties;

     (8)  Establish an affirmative defense for, and a conclusive basis for, certain violations;

     (9)  Establish a cannabis cultivator license to authorize the cultivation and distribution of cannabis plants;

    (10)  Require the Department of Health to only issue one cannabis cultivator license for each person;

    (11)  Establish limits on:

          (A)  The number of cannabis cultivator licenses the Department of Health may issue;

          (B)  The maximum size of plant canopy for indoor and outdoor cultivations for each cannabis cultivator license; and

          (C)  The maximum plant count of mature cannabis plants for each cannabis cultivator license;

    (12)  Authorize expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances relating to chapter 329D, Hawaii Revised Statutes (HRS); and

    (13)  Appropriate funds out of the Medical Cannabis Registry and Regulation Special Fund for the Department of Attorney General to enforce, and mitigate nuisances relating to, chapter 329D, HRS.

     Your Committees received testimony in support of this measure from the Hawaiʻi Cannabis Industry Association, Aloha Green Apothecary, Marijuana Policy Project, Cure Oahu, Big Island Grown Dispensaries, Hawaiʻi Alliance for Cannabis Reform, Drug Policy Forum of Hawaii, ACLU of Hawaiʻi, and one individual.

     Your Committees received testimony in opposition to this measure from the Oahu Cannabis Farms Alliance.

     Your Committees received comments on this measure from the Department of the Attorney General, Department of Health, Akamai Cannabis Consulting, and one individual.

     Your Committees find that the State's medical dispensary program is suffering from regulatory barriers that make operations difficult to sustain while facing increasing threats of competition from the unregulated market, including street sales and the proliferation of unregulated, high-potency THC cannabis, sold under the guise of being hemp, currently available at retailers across the State.  This measure will lower the barrier to entry for patients to access the legal dispensary system while maintaining quality standards for licensees to ensure access to clean and tested cannabis.

     Your Committees note that this measure, as written, establishes a criminal offense for unlicensed operation of a dispensary; however, the required state of mind is not clearly stated, and therefore amendments to this measure are necessary.

     Accordingly, your Committees have amended this measure by:

     (1)  Clarifying that the state of mind requirement for the offense of operating a dispensary without a license from the Department of Health pursuant to chapter 329D, HRS, is intentionally, knowingly, or recklessly;

     (2)  Specifying that a person who intentionally, knowingly, or recklessly operates any search platform, web hosting service, social media platform, or other entity that posts information advertising the sale of cannabis products by an unlicensed person or entity engaged in the production, manufacture, or sale of cannabis or manufactured cannabis products without a license pursuant to chapter 329D, HRS, is guilty of a misdemeanor;

     (3)  Specifying that a person issued a cannabis cultivator license is required to meet all production facility and processing requirements under chapter 329D, HRS;

     (4)  Inserting language specifying that the Department of the Attorney General's Drug Nuisance Abatement Unit may enforce nuisances relating to chapter 329D, HRS;

     (5)  Specifying that the appropriation for the Department of the Attorney General to enforce, and mitigate nuisances relating to, chapter 329D, HRS, shall be expended by the Attorney General;

     (6)  Inserting an effective date of January 1, 2027, for the requirement of cannabis cultivator licenses; and

     (7)  Making technical, nonsubstantive amendments for the purposes of clarity and consistency.

     As affirmed by the records of votes of the members of your Committees on Judiciary and Ways and Means that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 302, H.D. 2, S.D. 1, as amended herein, and recommend that it pass Third Reading in the form attached hereto as H.B. No. 302, H.D. 2, S.D. 2.

Respectfully submitted on behalf of the members of the Committees on Judiciary and Ways and Means,

STAND. COM. REP. NO. 1329

Honolulu, Hawaii

RE:    H.B. No. 302

       H.D. 2

       S.D. 1

Honorable Ronald D. Kouchi

President of the Senate

Thirty-Third State Legislature

Regular Session of 2025

State of Hawaii

Sir:

     Your Committees on Health and Human Services and Commerce and Consumer Protection, to which was referred H.B. No. 302, H.D. 2, entitled:

"A BILL FOR AN ACT RELATING TO CANNABIS,"

beg leave to report as follows:

     The purpose and intent of this measure is to repeal the requirement that a provider-patient relationship be established in person.

     Your Committees received testimony in support of this measure from the Department of Health, Hawai'i Cannabis Industry Association, ACLU of Hawai'i, Marijuana Policy Project, Hawaiʻi Alliance for Cannabis Reform, Cure Oahu, Ohana Unity Party, Big Island Grown Dispensaries, Drug Policy Forum of Hawaii, and three individuals.

     Your Committees received comments on this measure from Akamai Cannabis Consulting.

     Your Committees find that access for qualifying patients and primary caregivers to medical cannabis and particularly licensed medical cannabis dispensaries remains challenging due to limited access to medical providers, delays in obtaining allowed access to enter and purchase medical cannabis, and the availability of cannabis through a thriving illicit market.  Your Committees further find that registration for the medical cannabis program has decreased in the last few years, indicating that residents are shifting away from licensed medical cannabis dispensaries, and instead are obtaining their medical cannabis from elsewhere due to administrative barriers, delays in registering, and the ease and lower costs of obtaining cannabis elsewhere.  Your Committees believe that this apparent shift away from licensed medical cannabis dispensaries toward the illicit market undermines the purposes of the medical cannabis program in ensuring patient safety, product safety, and public safety.  This measure improves and increases access to medical cannabis in the State by allowing a patient-provider relationship to be established via telehealth for the purposes of certifying patients for the medical use of cannabis.

     Your Committees have amended this measure by:

     (1)  Inserting language to amend the definition of "debilitating medical condition" in section 329-121, Hawaii Revised Statutes, to mean any condition determined by the certifying physician or advanced practice registered nurse to be appropriate for the medical use of cannabis;

     (2)  Inserting language to amend the definition of "waiting room" in section 329D-1, Hawaii Revised Statutes, to include an area where hemp can be sold, including but not limited to hemp products and accessories to the use of medical cannabis, such as rolling papers, rolling trays, grinders, and vaporizers;

     (3)  Inserting language to amend section 329D-6(r), Hawaii Revised Statutes, to:

          (A)  Require that cannabis and manufactured cannabis products purchased by a dispensary from another dispensary pursuant to section 329D-6, Hawaii Revised Statutes:

              (i)  When intended for direct retail sale to the patient, meet all applicable packaging, labeling, and testing requirements at the time of transport to the purchasing licensee's production center or one of its retail locations; and

             (ii)  When intended for further manufacturing by the purchasing dispensary at the time of transportation, be transported to the purchasing licensee's production center; and

          (B)  Require the selling dispensary to submit a transport manifest of the cannabis or manufactured cannabis products to be sold to the Department of Health before the sale is made, after which the selling dispensary may immediately proceed with the transfer of the cannabis or manufactured cannabis products;

     (4)  Inserting as Part II of this measure, the contents of S.B. No. 1064, S.D. 2, Regular Session of 2025, which:

          (A)  Prohibits persons from:

              (i)  Operating a medical cannabis dispensary or cultivating cannabis without a license from the Department of Health; and

             (ii)  Providing certain services to persons and entities engaging in unlicensed cannabis operations;

          (B)  Requires the Department of Health to issue a cease and desist notice to violators before initiating criminal proceedings;

          (C)  Establishes criminal penalties, an affirmative defense, a conclusive basis, and exceptions for certain violations;

          (D)  Establishes a cannabis cultivator license to authorize the cultivation and distribution of cannabis plants;

          (E)  Requires the Department of Health to only issue one cannabis cultivator license for each person;

          (F)  Establishes limits on:

              (i)  The number of cannabis cultivator licenses the Department of Health may issue;

             (ii)  The maximum size of plant canopy for indoor and outdoor cultivations for each cannabis cultivator license; and

            (iii)  The maximum plant count of mature cannabis plants for each cannabis cultivator license;

          (G)  Authorizes expenditures from the Medical Cannabis Registry and Regulation Special Fund to fund programs for the mitigation and abatement of nuisances relating to chapter 329D, Hawaii Revised Statutes; and

          (H)  Appropriates funds out of the Medical Cannabis Registry and Regulation Special Fund for the Department of Attorney General to enforce, and mitigate nuisances relating to, chapter 329D, Hawaii Revised Statutes;

     (5)  Amending section 1 to reflect its amended purpose;

     (6)  Inserting an effective date of December 31, 2050, to encourage further discussion; and

     (7)  Making technical, nonsubstantive amendments for the purposes of clarity and consistency.

     As affirmed by the records of votes of the members of your Committees on Health and Human Services and Commerce and Consumer Protection that are attached to this report, your Committees are in accord with the intent and purpose of H.B. No. 302, H.D. 2, as amended herein, and recommend that it pass Second Reading in the form attached hereto as H.B. No. 302, H.D. 2, S.D. 1, and be referred to your Committee on Judiciary.

Respectfully submitted on behalf of the members of the Committees on Health and Human Services and Commerce and Consumer Protection,

STAND. COM. REP. NO.  1079

Honolulu, Hawaii

                , 2025

RE:   H.B. No. 302

      H.D. 2

Honorable Nadine K. Nakamura

Speaker, House of Representatives

Thirty-Third State Legislature

Regular Session of 2025

State of Hawaii

Madame:

     Your Committee on Judiciary & Hawaiian Affairs, to which was referred H.B. No. 302, H.D. 2, entitled:

"A BILL FOR AN ACT RELATING TO CANNABIS,"

begs leave to report as follows:

     The purpose of this measure is to repeal the requirement that a provider-patient relationship be established in person for the purposes of certifying a qualifying patient for the medical use of cannabis, with certain restrictions.

     Your Committee received testimony in support of this measure from the Department of Health; Aloha Green Apothecary; Cure Oahu; Hawai‘i Cannabis Industry Association; and Big Island Grown.  Your Committee received comments on this measure from Akamai Cannabis Consulting.

     Your Committee finds that the existing medical cannabis laws prohibit the issuance of a written certification for the use of medical cannabis by means of telehealth unless a bona fide provider-patient relationship has been previously established in person.  Your Committee further finds that the laws relating to telehealth were revised in 2021, which for all other medications except for opiates and medical cannabis, allows the issuance of prescriptions through telehealth consultations without the establishment of a bona fide provider-patient relationship in person.  This differentiated treatment of medical cannabis from other medications appears arbitrary and this measure eliminates this barrier, providing greater access to necessary medication for patients.

     As affirmed by the record of votes of the members of your Committee on Judiciary & Hawaiian Affairs that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 302, H.D. 2, and recommends that it pass Third Reading.

Respectfully submitted on behalf of the members of the Committee on Judiciary & Hawaiian Affairs,

STAND. COM. REP. NO.  428

Honolulu, Hawaii

                , 2025

RE:   H.B. No. 302

      H.D. 2

Honorable Nadine K. Nakamura

Speaker, House of Representatives

Thirty-Third State Legislature

Regular Session of 2025

State of Hawaii

Madame:

     Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 302, H.D. 1, entitled:

"A BILL FOR AN ACT RELATING TO CANNABIS,"

begs leave to report as follows:

     The purpose of this measure is to:

     (1)  Repeal the requirement that a provider-patient relationship be established in person for purposes of obtaining a certification for medical cannabis; and

     (2)  Allow applicants or primary caregivers to temporarily purchase medical cannabis after the submission of the applicant's certification form.

     Your Committee received testimony in support of this measure from the Hawaiʻi Cannabis Industry Association; Cure Oahu; Big Island Grown; Noa Botanicals; and one individual.  Your Committee received comments on this measure from the Department of the Attorney General; Department of Health; and Akamai Cannabis Consulting.

     Your Committee finds that the number of registered medical cannabis patients has been in decline since 2021.  There are various issues with the registration process, particularly the number of providers participating in the certification process.  This measure eases the hurdle of access to participating providers by repealing the requirement that a provider-patient relationship be established in person for purposes of obtaining a certification for medical cannabis.

     Your Committee has amended this measure by:

     (1)  Specifying that written certifications must originate from within the State;

     (2)  Deleting language that allowed applicants or primary caregivers to temporarily purchase medical cannabis after the submission of the applicant's certification form; and

     (3)  Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.

     As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 302, H.D. 1, as amended herein, and recommends that it be referred to your Committee on Judiciary & Hawaiian Affairs in the form attached hereto as H.B. No. 302, H.D. 2.

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

STAND. COM. REP. NO.  33

Honolulu, Hawaii

                , 2025

RE:   H.B. No. 302

      H.D. 1

Honorable Nadine K. Nakamura

Speaker, House of Representatives

Thirty-Third State Legislature

Regular Session of 2025

State of Hawaii

Madame:

     Your Committee on Health, to which was referred H.B. No. 302 entitled:

"A BILL FOR AN ACT RELATING TO CANNABIS,"

begs leave to report as follows:

     The purpose of this measure is to:

     (1)  Repeal the requirement that a provider-patient relationship be established in person for purposes of obtaining a certification for medical cannabis; and

     (2)  Allow applicants or primary caregivers to temporarily purchase medical cannabis after the submission of the applicant's certification form.

     Your Committee received testimony in support of this measure from the Hawai‘i Cannabis Industry Association; Aloha Green Apothecary; Cure Oahu; Noa Botanicals; and Big Island Grown Dispensaries.  Your Committee received comments on this measure from the Department of the Attorney General; Department of Health; and Akamai Cannabis Consulting.

     Your Committee finds that access for qualifying patients and primary caregivers to medical cannabis remains challenging due to limited access to medical providers, delays in obtaining authorizations for access to enter and purchase medical cannabis from licensed medical cannabis dispensaries, and a thriving illicit market.  Your Committee further finds that between August 2021 and November 2024, the number of registered card-holding patients in Hawaii decreased by fifteen percent, indicating that qualifying patients are shifting away from licensed medical cannabis dispensaries and instead obtaining their medical cannabis from elsewhere.  Your Committee believes that reducing some of the administrative barriers to accessing medical cannabis, as intended by this measure, will support the State's medical cannabis program and encourage qualifying patients to access medical cannabis in a manner that ensures patient safety, product safety, and public safety.

     Your Committee has amended this measure by:

     (1)  Changing the effective date to July 1, 3000, to encourage further discussion; and

     (2)  Making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.

     As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 302, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 302, H.D. 1, and be referred to your Committee on Consumer Protection & Commerce.

Respectfully submitted on behalf of the members of the Committee on Health,